These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 33472858)
41. NK cell phenotypic modulation in lung cancer environment. Jin S; Deng Y; Hao JW; Li Y; Liu B; Yu Y; Shi FD; Zhou QH PLoS One; 2014; 9(10):e109976. PubMed ID: 25299645 [TBL] [Abstract][Full Text] [Related]
42. Stage-Specific Requirement for Eomes in Mature NK Cell Homeostasis and Cytotoxicity. Wagner JA; Wong P; Schappe T; Berrien-Elliott MM; Cubitt C; Jaeger N; Lee M; Keppel CR; Marin ND; Foltz JA; Marsala L; Neal CC; Sullivan RP; Schneider SE; Keppel MP; Saucier N; Cooper MA; Fehniger TA Cell Rep; 2020 Jun; 31(9):107720. PubMed ID: 32492428 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models. Greene S; Robbins Y; Mydlarz WK; Huynh AP; Schmitt NC; Friedman J; Horn LA; Palena C; Schlom J; Maeda DY; Zebala JA; Clavijo PE; Allen C Clin Cancer Res; 2020 Mar; 26(6):1420-1431. PubMed ID: 31848188 [TBL] [Abstract][Full Text] [Related]
45. The temporal progression of lung immune remodeling during breast cancer metastasis. McGinnis CS; Miao Z; Superville D; Yao W; Goga A; Reticker-Flynn NE; Winkler J; Satpathy AT Cancer Cell; 2024 Jun; 42(6):1018-1031.e6. PubMed ID: 38821060 [TBL] [Abstract][Full Text] [Related]
46. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta. Arteaga CL; Koli KM; Dugger TC; Clarke R J Natl Cancer Inst; 1999 Jan; 91(1):46-53. PubMed ID: 9890169 [TBL] [Abstract][Full Text] [Related]
47. TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer. Slattery K; Woods E; Zaiatz-Bittencourt V; Marks S; Chew S; Conroy M; Goggin C; MacEochagain C; Kennedy J; Lucas S; Finlay DK; Gardiner CM J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33568351 [TBL] [Abstract][Full Text] [Related]
48. Enhanced NK cell adoptive antitumor effects against breast cancer in vitro via blockade of the transforming growth factor-β signaling pathway. Zhao Y; Hu J; Li R; Song J; Kang Y; Liu S; Zhang D Onco Targets Ther; 2015; 8():1553-9. PubMed ID: 26124672 [TBL] [Abstract][Full Text] [Related]
49. Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells. Goding SR; Yu S; Bailey LM; Lotze MT; Basse PH Clin Immunol; 2017 Apr; 177():76-86. PubMed ID: 27377534 [TBL] [Abstract][Full Text] [Related]
50. Induction of tumor NK-cell immunity by anti-CD69 antibody therapy. Esplugues E; Vega-Ramos J; Cartoixà D; Vazquez BN; Salaet I; Engel P; Lauzurica P Blood; 2005 Jun; 105(11):4399-406. PubMed ID: 15692061 [TBL] [Abstract][Full Text] [Related]
51. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma. Sui Q; Zhang J; Sun X; Zhang C; Han Q; Tian Z J Immunol; 2014 Aug; 193(4):2016-23. PubMed ID: 25015826 [TBL] [Abstract][Full Text] [Related]
52. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment. Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832 [TBL] [Abstract][Full Text] [Related]
53. NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors. Alvarez-Breckenridge CA; Yu J; Price R; Wojton J; Pradarelli J; Mao H; Wei M; Wang Y; He S; Hardcastle J; Fernandez SA; Kaur B; Lawler SE; Vivier E; Mandelboim O; Moretta A; Caligiuri MA; Chiocca EA Nat Med; 2012 Dec; 18(12):1827-34. PubMed ID: 23178246 [TBL] [Abstract][Full Text] [Related]
54. Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles. Garcia Z; Lemaître F; van Rooijen N; Albert ML; Levy Y; Schwartz O; Bousso P Blood; 2012 Dec; 120(24):4744-50. PubMed ID: 23065157 [TBL] [Abstract][Full Text] [Related]
55. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts. van der Touw W; Burrell B; Lal G; Bromberg JS Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174 [TBL] [Abstract][Full Text] [Related]
56. Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions. Liu J; Wu S; Zheng X; Zheng P; Fu Y; Wu C; Lu B; Ju J; Jiang J Sci Rep; 2020 Sep; 10(1):14749. PubMed ID: 32901082 [TBL] [Abstract][Full Text] [Related]
57. The absence or overexpression of IL-15 drastically alters breast cancer metastasis via effects on NK cells, CD4 T cells, and macrophages. Gillgrass A; Gill N; Babian A; Ashkar AA J Immunol; 2014 Dec; 193(12):6184-91. PubMed ID: 25355926 [TBL] [Abstract][Full Text] [Related]
58. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. Li H; Han Y; Guo Q; Zhang M; Cao X J Immunol; 2009 Jan; 182(1):240-9. PubMed ID: 19109155 [TBL] [Abstract][Full Text] [Related]
59. Natural cytotoxicity receptor 1 in mouse uNK cell maturation and function. Felker AM; Croy BA Mucosal Immunol; 2017 Sep; 10(5):1122-1132. PubMed ID: 28098245 [TBL] [Abstract][Full Text] [Related]
60. Shevtsov M; Pitkin E; Ischenko A; Stangl S; Khachatryan W; Galibin O; Edmond S; Lobinger D; Multhoff G Front Immunol; 2019; 10():454. PubMed ID: 30967859 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]